| Epirubicin studied in …STUDIED_INderived200 of 285show all (up to 200) |
|---|
| → studied in | NCT05901428Phase 3 · recruiting TCb vs EC-T in High Risk ER+/HER2- Breast Cancer · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06966700Phase 3 · recruiting A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) · 285 trials list this drug (47 active) | — | — | Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06227065Phase 2 · not yet recruiting Precise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids · 285 trials list this drug (47 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06797635Phase 2 · recruiting Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) · 285 trials list this drug (47 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860529Phase 2 · recruiting Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07753642Phase 2 · not yet recruiting Golidocitinib Plus Anthracycline-based Therapy for Untreated Nodal T-follicular Helper (TFH) Cell Lymphoma · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07424287Phase 3 · recruiting A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC · 285 trials list this drug (47 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06964906Phase 2 · recruiting Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024734Phase 2 · active not recruiting Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids · 285 trials list this drug (47 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06112379Phase 3 · active not recruiting A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05582499Phase 2 · recruiting Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy · 285 trials list this drug (47 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Early Stage Breast Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07320508Phase 2 · recruiting Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study · 285 trials list this drug (47 active) | — | — | Adenoid Cystic Carcinoma,Sinonasal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03286634Phase 2 · active not recruiting ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 · 285 trials list this drug (47 active) | — | — | Childhood Malignant Neoplasm,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04771871Phase 2 · recruiting MicroRNA Profiles in Triple Negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00433420Phase 3 · active not recruiting Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00872625Phase 1 · completed Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04433156Phase 2 · completed VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma · 285 trials list this drug (47 active) | — | — | Marginal Zone Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07441460Phase 3 · recruiting A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast Cancer · 285 trials list this drug (47 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04877821Phase 2 · completed The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC · 285 trials list this drug (47 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066443Phase 1/Phase 2 · completed Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06829199Phase 2 · withdrawn A Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003) · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06291064Phase 2 · recruiting Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04067037Phase 2 · active not recruiting Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma · 285 trials list this drug (47 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04770272Phase 2 · terminated Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy · 285 trials list this drug (47 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04290793Phase 2/Phase 3 · active not recruiting Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04872985Phase 2 · active not recruiting Pyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06107673Phase 2 · recruiting Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC） · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01358877Phase 3 · completed A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04193059Phase 3 · active not recruiting Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214626Phase 2 · completed R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma · 285 trials list this drug (47 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07016399Phase 2 · recruiting Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC · 285 trials list this drug (47 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03036488Phase 3 · completed Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522) · 285 trials list this drug (47 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05900206Phase 2 · recruiting Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005584Phase 3 · active not recruiting Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma · 285 trials list this drug (47 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03725059Phase 3 · active not recruiting Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01630083Phase 2 · completed Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04668365Phase 2 · suspended Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma · 285 trials list this drug (47 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06140966Phase 2 · recruiting Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma · 285 trials list this drug (47 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01779206Phase 2/Phase 3 · completed ADAPT - Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04296175Phase 3 · active not recruiting Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE) · 285 trials list this drug (47 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06699576Phase 1 · not yet recruiting ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma. · 285 trials list this drug (47 active) | — | — | Osteosarcoma,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03356860Phase 1/Phase 2 · completed Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer. · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm,Luminal B Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06692491Phase 2 · not yet recruiting Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS · 285 trials list this drug (47 active) | — | — | Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03013504Phase 3 · completed A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients · 285 trials list this drug (47 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03277924Phase 1/Phase 2 · completed Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas · 285 trials list this drug (47 active) | — | — | Bone Sarcoma,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06470633Phase 2 · not yet recruiting To Evaluate the Efficacy of Adebrelimab Combined With Chemotherapy After HIFU Induction Neoadjuvant Therapy HR+/HER2- Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06389006Phase 2 · recruiting To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04418154Phase 2 · unknown Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients · 285 trials list this drug (47 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06404463Phase 2 · not yet recruiting QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk ER+/HER2- Breast Cancer · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03272477Phase 2 · completed Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06309732Phase 2 · completed GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT) · 285 trials list this drug (47 active) | — | — | Testicular Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00630032Phase 3 · completed Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00486356Phase 1 · completed Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer · 285 trials list this drug (47 active) | — | — | Adult Solid Neoplasm,Malignant Gastric Neoplasm,Malignant Gallbladder Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05978648Phase 2 · recruiting Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02287129Phase 2 · completed Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction · 285 trials list this drug (47 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06121570Phase 1 · recruiting Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04172259Phase 2 · active not recruiting ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983094Phase 2 · not yet recruiting Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05981014Phase 1/Phase 2 · recruiting Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05887726Phase 2 · unknown Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors · 285 trials list this drug (47 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05883852Phase 3 · recruiting EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05447702Phase 2 · recruiting Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) · 285 trials list this drug (47 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00432172Phase 2 · completed Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00129935Phase 3 · completed EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00841828Phase 2 · completed Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01036087Phase 2 · completed Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02315196Phase 2 · active not recruiting Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00129922Phase 3 · completed Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05681728Phase 2 · unknown A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05678933Phase 3 · enrolling by invitation AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00773695Phase 2 · completed A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05656079NA · unknown To Evaluate the Cardiac Safety of Pegylated Liposomal Doxorubicin Concurrently Plus Trastuzumab and Pertuzumab in the Adjuvant Setting for Early-stage HER-2-positive Breast Cancer: a Multicenter, Randomized Controlled Clinical Study · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02752815Phase 4 · unknown Reduced Chemotherapy in Low Risk DLBCL · 285 trials list this drug (47 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01779050Phase 2 · terminated Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02549677Phase 4 · completed Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01726452Phase 3 · completed NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS) · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087178Phase 3 · completed Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05491694Phase 2 · unknown To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05472896Phase 3 · unknown TACE With Dicycloplatin(TP21) in Unresectable HCC · 285 trials list this drug (47 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05420454Phase 4 · recruiting A Study for the Neoadjuvant Treatment of Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05420467Phase 4 · recruiting A Study for the Adjuvant Treatment of Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01966471Phase 3 · completed A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02897050Phase 2 · suspended Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01929811Phase 2 · terminated NeoMET Study in Neoadjuvant Treatment of Breast Cancer · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05287308NA · not yet recruiting Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02050919Phase 2 · completed Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma · 285 trials list this drug (47 active) | — | — | Adult Soft Tissue Sarcoma,Pleomorphic Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02400567Phase 2 · completed Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04736394Phase 3 · unknown A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05121350Phase 3 · unknown A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma · 285 trials list this drug (47 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03556358Phase 3 · completed Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00193206Phase 2 · completed Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05131893not yet recruiting Neoadjuvant Treatment of Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00193050Phase 2 · completed Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02395640Phase 3 · completed The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer · 285 trials list this drug (47 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00464646Phase 2 · completed Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02742051Phase 2 · completed A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03894007Phase 2 · terminated Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer · 285 trials list this drug (47 active) | — | — | Early Stage Breast Carcinoma,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01593020Phase 2 · completed Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05053386NA · unknown Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma · 285 trials list this drug (47 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02132949Phase 2 · completed A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576143Phase 2/Phase 3 · recruiting Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04717531Phase 2 · unknown Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01220128Phase 2 · terminated Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04899570Phase 2 · unknown Zanubrutinib Combined With R-CHOP in Newly-diagnosed Intravascular Large B-cell Lymphoma · 285 trials list this drug (47 active) | — | — | Intravascular Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02909751Phase 2 · completed Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03289819Phase 2 · completed Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003606Phase 3 · completed Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer · 285 trials list this drug (47 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02324088Phase 3 · completed Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02685059Phase 2 · completed Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in Triple Negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04738188NA · unknown Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria; · 285 trials list this drug (47 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01690702Phase 3 · completed Study of Nab-Paclitaxel in High Risk Early Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02682693Phase 2 · completed Denosumab as an add-on Neoadjuvant Treatment (GeparX) · 285 trials list this drug (47 active) | — | — | Breast Inflammatory Carcinoma,Breast Mucinous Carcinoma,Breast Tubular Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04676997Phase 2 · unknown Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC) · 285 trials list this drug (47 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04659551Phase 2 · completed Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00309569Phase 3 · completed Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients · 285 trials list this drug (47 active) | — | — | Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014222Phase 3 · completed Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00625898Phase 3 · terminated BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04498793Phase 2 · unknown Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00253500Phase 2 · completed Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02971345Phase 3 · unknown Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus · 285 trials list this drug (47 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01026116Phase 3 · completed A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years Old · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052910Phase 3 · completed Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer · 285 trials list this drug (47 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04031703Phase 3 · completed Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN) · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002542Phase 3 · completed Tamoxifen in Treating Women With High-Risk Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002866Phase 1 · completed Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01855828Phase 2 · completed Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer · 285 trials list this drug (47 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02879513Phase 3 · unknown Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy · 285 trials list this drug (47 active) | — | — | Breast Inflammatory Carcinoma,Breast Mucinous Carcinoma,Breast Tubular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04127019Phase 3 · completed Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER) · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04224922Phase 2 · completed Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00820547Phase 2 · completed Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02076594Phase 3 · terminated Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer · 285 trials list this drug (47 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02115204Phase 3 · completed 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869192Phase 2 · completed Phase II Trial for Large ER-Negative Breast Cancers · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01049425Phase 3 · completed Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast Cancer · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01216644Phase 2/Phase 3 · completed 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer · 285 trials list this drug (47 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00601705Phase 2 · completed Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach · 285 trials list this drug (47 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03925233unknown Breast Cancer Treatment Based on Organ-like Culture · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03123770Phase 4 · unknown Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03876886Phase 3 · unknown The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency · 285 trials list this drug (47 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02177552Phase 2 · unknown Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma · 285 trials list this drug (47 active) | — | — | Esophageal Neoplasm,Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00513292Phase 3 · completed Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01386346Phase 1 · completed Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer · 285 trials list this drug (47 active) | — | — | Esophageal Neoplasm,Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03647280NA · unknown The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03756090NA · unknown The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00215644Phase 2 · completed Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer · 285 trials list this drug (47 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03668418unknown Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos · 285 trials list this drug (47 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm,Malignant Pancreatic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00822848Phase 1 · completed Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma · 285 trials list this drug (47 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00954512Phase 1/Phase 2 · terminated Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) · 285 trials list this drug (47 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01690325Phase 2 · terminated Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON) · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00301925Phase 3 · unknown Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01830270Phase 2 · terminated Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer · 285 trials list this drug (47 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096304Phase 1 · terminated Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer · 285 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00559845Phase 2 · completed A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01624441Phase 1 · completed Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Carcinoma,Male Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02214602Phase 4 · completed Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer · 285 trials list this drug (47 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00950300Phase 3 · completed A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03373708Phase 2/Phase 3 · unknown Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03349177Phase 2/Phase 3 · unknown Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00722293Phase 1 · completed A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02694224Phase 2 · unknown Addition of Vismodegib to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02760953NA · unknown TURBt With Adjuvant Cryoablation to Treat Bladder Cancer · 285 trials list this drug (47 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03273595Phase 2 · unknown Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01150630Phase 2 · completed Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer · 285 trials list this drug (47 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02871869Phase 2/Phase 3 · unknown Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma · 285 trials list this drug (47 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02125344Phase 3 · completed A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) · 285 trials list this drug (47 active) | — | — | Breast Inflammatory Carcinoma,Breast Mucinous Carcinoma,Breast Tubular Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01205217Phase 2 · withdrawn Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00878904Phase 1 · completed Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors · 285 trials list this drug (47 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00176488Phase 2 · terminated Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00246103Phase 1 · completed Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies · 285 trials list this drug (47 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02987244Phase 1/Phase 2 · unknown Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma · 285 trials list this drug (47 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017186Phase 2 · completed Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma · 285 trials list this drug (47 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450203Phase 2/Phase 3 · unknown Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00499603Phase 2 · unknown Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02949258Phase 2 · unknown Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer · 285 trials list this drug (47 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01123473Phase 2 · terminated Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer · 285 trials list this drug (47 active) | — | — | Malignant Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454636Phase 2 · completed A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. · 285 trials list this drug (47 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00379015Phase 2 · completed Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00957125Phase 2 · unknown A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer Early · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02846428Phase 2 · completed To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003852Phase 2 · terminated Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors · 285 trials list this drug (47 active) | — | — | Childhood Germ Cell Tumor,Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01503905NA · unknown Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients · 285 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00429299Phase 2 · completed Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00322374Phase 1 · completed Phase I Combination w/ Epirubicin · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00130936Phase 1/Phase 2 · terminated Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates · 285 trials list this drug (47 active) | — | — | Neoplasm,Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00753207Phase 1 · completed Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30 · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01697072Phase 3 · terminated First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma · 285 trials list this drug (47 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00540800Phase 3 · completed BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02638857Phase 1/Phase 2 · unknown Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma · 285 trials list this drug (47 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02631499Phase 4 · unknown Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation · 285 trials list this drug (47 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02627248Phase 4 · unknown Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01985841Phase 2 · terminated Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01433614Phase 3 · completed Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02510781Phase 2 · unknown A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCs · 285 trials list this drug (47 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02450058Phase 3 · completed Adjuvant FEC Versus EP in Breast Cancer (MIG5) · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00424606Phase 3 · completed Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01167738Phase 2 · terminated Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer · 285 trials list this drug (47 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00146588NA · completed Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00615602Phase 3 · completed Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00755976Phase 2 · completed Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma · 285 trials list this drug (47 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002870Phase 3 · completed High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer · 285 trials list this drug (47 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |